tiprankstipranks
Argenica Therapeutics Ltd (AU:AGN)
:AGN
Australian Market

Argenica Therapeutics Ltd (AGN) Financial Statements

Compare
10 Followers

Argenica Therapeutics Ltd Financial Overview

Argenica Therapeutics Ltd's market cap is currently ―. The company's EPS TTM is AU$-0.047; its P/E ratio is ―; Argenica Therapeutics Ltd is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total RevenueAU$ 2.60MAU$ 1.75MAU$ 259.10KAU$ 296.07KAU$ 0.00
Gross ProfitAU$ 2.60MAU$ 1.75MAU$ 259.10KAU$ 296.07KAU$ 0.00
Operating IncomeAU$ -5.67MAU$ -6.62MAU$ -4.09MAU$ -1.03MAU$ -383.65K
EBITDAAU$ -1.90MAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Net IncomeAU$ -5.48MAU$ -4.82MAU$ -4.09MAU$ -1.03MAU$ -383.40K
Balance Sheet
Cash & Short-Term InvestmentsAU$ 15.91MAU$ 9.34MAU$ 8.91MAU$ 7.14MAU$ 341.98K
Total AssetsAU$ 16.38MAU$ 9.54MAU$ 9.04MAU$ 7.27MAU$ 377.66K
Total DebtAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -15.91MAU$ -9.29MAU$ -8.91MAU$ -7.14MAU$ -341.98K
Total LiabilitiesAU$ 2.43MAU$ 1.87MAU$ 735.91KAU$ 425.72KAU$ 359.26K
Stockholders' EquityAU$ 13.95MAU$ 7.67MAU$ 8.31MAU$ 6.85MAU$ 18.40K
Cash Flow
Free Cash FlowAU$ -5.06MAU$ -3.30MAU$ -3.36MAU$ -1.05MAU$ -58.82K
Operating Cash FlowAU$ -5.06MAU$ -3.30MAU$ -3.36MAU$ -1.05MAU$ -58.82K
Investing Cash FlowAU$ 50.00KAU$ -50.00KAU$ 0.00AU$ 0.00AU$ 0.00
Financing Cash FlowAU$ 11.63MAU$ 3.73MAU$ 5.13MAU$ 7.85MAU$ 400.80K
Currency in AUD

Argenica Therapeutics Ltd Earnings and Revenue History

Argenica Therapeutics Ltd Debt to Assets

Argenica Therapeutics Ltd Cash Flow

Argenica Therapeutics Ltd Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis